How does Fruzaqla work?

  • Targeted Therapy: Fruzaqla is designed to target specific proteins involved in the growth of GIST cells.
  • Inhibits Tumor Growth: By blocking these proteins, Fruzaqla can help slow down or stop the growth of GIST tumors.

Who is Fruzaqla for?


Fruzaqla is typically used for patients with advanced GIST who have already received treatment with other targeted therapies, such as imatinib.

Important Note:

  • Always consult with your healthcare provider to determine if Fruzaqla is right for you.
  • Discuss potential side effects and benefits with your doctor.
  • Adhere to the prescribed dosage and schedule as recommended by your healthcare provider.

Symptoms of GIST:

  • Abdominal pain or discomfort
  • Abdominal mass or lump
  • Gastrointestinal bleeding
  • Early satiety
  • Weight loss
  • Fatigue
  • Anemia

Treatment Options for GIST:

The treatment for GIST depends on several factors, including the size, location, and stage of the tumor, as well as the patient's overall health. Common treatment options include:

Surgery:

  • Surgical Resection: This involves removing the tumor and a margin of healthy tissue.
  • Endoscopic Resection: In some cases, the tumor can be removed using minimally invasive endoscopic techniques.

Targeted Therapy:

  • Imatinib: This is a targeted therapy that blocks a specific protein that helps cancer cells grow.
  • Sunitinib: Another targeted therapy that can be used to treat advanced GIST.
  • Regorafenib: A targeted therapy that can be used for patients who have progressed on other treatments.
  • Fruquintinib: A newer targeted therapy that has shown promise in treating advanced GIST.

Clinical Trials:

  • Participating in clinical trials can provide access to new treatments and contribute to medical research.

It's important to consult with an oncologist to discuss the best treatment options for your specific situation. Early diagnosis and prompt treatment can significantly improve the outlook for patients with GIST.